Fig. 4
From: Uptake of new antidiabetic medicines in 11 European countries
![Fig. 4](http://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12902-021-00798-3/MediaObjects/12902_2021_798_Fig4_HTML.png)
Correlation between the ratio (2011 compared to 2007) of intensity of prescribing policy for all antidiabetic medicines and volume market share of incretin-based medicines (DDP-4 inhibitors and GLP-1 receptor agonists) in 2011